Soligenix Inc (OTCBB - OTCQB:SNGX)

1.98
Data as of Oct 24
 +0.02 / +1.02%
Today’s Change
1.29
Today|||52-Week Range
2.50
+10.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$39.4M

Company Description

Soligenix, Inc. is a clinical stage biopharmaceutical company. It is focused on developing products to treat serious gastrointestinal diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics. The company operates through BioTherapeutics and Vaccines/BioDefense segments. The BioTherapeutics segment intends to develop oral beclomethasone dipropionate indications such as pediatric crohn's disease and acute radiation enteritis. The Vaccines/BioDefense segment includes active development programs for RiVax, its ricin toxin vaccine, and VeloThrax, its anthrax vaccine, and OrbeShield, its gastrointestinal acute radiation syndrome therapeutic. Soligenix was founded in 1987 and is headquartered Princeton, NJ.

Contact Information

Soligenix, Inc.
29 Emmons Drive
Princeton New Jersey 08540-5919
P:(609) 538-8200
Investor Relations:

Employees

Shareholders

Individual stakeholders22.88%
Mutual fund holders0.00%
Other institutional0.00%

Top Executives

Christopher J. SchaberChairman, President & Chief Executive Officer
Joseph Michael WaruszChief Financial Officer, Secretary & VP
Robert N. BreyChief Scientific Officer & Senior Vice President
Oreola DoniniVice President-Preclinical Research & Development
Richard C. StraubeChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.